Balyasny Asset Management LLC Anika Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.57 - $28.47 $226,977 - $263,005	9,238 New	9,238 $233,000
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $84,056 - $106,038	4,551 Added 45.27%	14,605 $330,000
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $170,716 - $262,409	10,054 New	10,054 $187,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $419,206 - $542,810	-12,769 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $229,268 - $384,663	7,969 Added 166.02%	12,769 $409,000
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $182,114 - $253,191	-3,700 Reduced 43.53%	4,800 $239,000
Q4 2017 Feb 14, 2018	BUY	$52.14 - $59.94 $443,190 - $509,490	8,500	8,500 $458,000

123

11.4M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $252M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.